Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
51 Results Found
340B Advocacy Alliance Bulletin - April 24, 2025
340B Advocacy Alliance Bulletin for April 24, 2025.
AHA 340B Advocacy Alliance
The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. District Court for the District of Columbia, urging the court to uphold the Health Resources and Services Administration’s decision to reject Johnson & Johnson’s proposed 340B rebate model in a lawsuit brought by J&J to bar the agency from doing so.
340B AHA Advocacy Alliance - March 7, 2025
AHA, others file amicus briefs opposing major drug companies’ 340B rebate models
AHA 340B Advocacy Alliance Bulletin: HRSA Issues Final Warning to J&J on 340B Proposal
The Health Resources and Services Administration today sent a final warning letter to Johnson & Johnson urging the company to inform the agency by Monday, Sept. 30 that it would halt its proposed 340B rebate model scheduled to go into effect next month.
AHA 340B Advocacy Alliance - January 6, 2025
AHA 340B Advocacy Alliance Bulletin for January 6, 2025.
340B Advocacy Alliance Bulletin - December 3, 2024
340B Advocacy Alliance Bulletin for December 3, 2024.
AHA 340B Advocacy Alliance Bulletin - December 16, 2024
AHA 340B Advocacy Alliance Bulletin for December 16, 2024.
AHA 340B Advocacy Alliance Bulletin - December 3, 2024
AHA 340B Advocacy Alliance Bulletin - December 3, 2024.
AHA 340B Advocacy Alliance Bulletin: December 12, 2024
AHA urges 340B members to complete a brief survey to help the association understand how a 340B rebate model — such as the one Johnson & Johnson sought to implement this year — would impact 340B member hospitals.
AHA 340B Advocacy Alliance Bulletin - October 4, 2024
The Department of Health and Human Services Oct. 2 released final guidance detailing the process for the second cycle of negotiations under the Medicare Drug Price Negotiation Program.